Long-Term Update of NRG Oncology RTOG 94-08

被引：4

作者：

Jones, C. U. ^{[1
]}

Pugh, S. ^{[2
]}

Sandler, H. M. ^{[3
]}

Chetner, M. P. ^{[4
]}

Amin, M. ^{[5
]}

Efstathiou, J. A. ^{[6
]}

Den, R. B. ^{[7
]}

Leibenhaut, M. H. ^{[1
]}

Longo, J. M. ^{[8
]}

Bahary, J. P. ^{[9
]}

Rosenthal, S. A. ^{[1
]}

Souhami, L. ^{[10
]}

Michalski, J. M. ^{[11
]}

Hartford, A. C. ^{[12
]}

Amin, P. P. ^{[13
]}

Roach, M., III ^{[14
]}

Yee, D. ^{[15
]}

Rodgers, J. ^{[2
]}

Shipley, W. U. ^{[6
]}

机构：

[1] Sutter Med Grp & Canc Ctr, Sacramento, CA USA

[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA

[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[4] Univ Alberta, Edmonton, AB, Canada

[5] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA

[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA

[7] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA

[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[9] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[10] McGill Univ Hlth Ctr, Montreal, PQ, Canada

[11] Washington Univ, Sch Med, St Louis, MO USA

[12] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

[13] Univ Maryland, Med Ctr, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[14] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[15] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2018.06.062

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S31 / S32

页数：2

共 50 条

[31] Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years
Chun, S. G.
Hu, C.
Choy, H.
Komaki, R. U.
Timmerman, R. D.
Schild, S. E.
Bogart, J. A.
Dobelbower, M. C.
Bosch, W.
Kavadi, V. S.
Narayan, S.
Iyengar, P.
Robinson, C. G.
Rothman, J.
Raben, A.
Augspurger, M. E.
Mcrae, R. M.
Paulus, R.
Bradley, J. D.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S83 - S84
[32] Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
Sartor, Oliver
Karrison, Theodore G.
Sandler, Howard M.
Gomella, Leonard G.
Amin, Mahul B.
Purdy, James
Michalski, Jeff M.
Garzotto, Mark G.
Pervez, Nadeem
Balogh, Alexander G.
Rodrigues, George B.
Souhami, Luis
Reaume, M. Neil
Williams, Scott G.
Hannan, Raquibul
Jones, Christopher U.
Horwitz, Eric M.
Rodgers, Joseph P.
Feng, Felix Y.
Rosenthal, Seth A.
EUROPEAN UROLOGY, 2023, 84 (02) : 156 - 163
[33] Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial (vol 112, pg 294, 2022)
Jones, C. U.
Pugh, S. L.
Sandler, H. M.
Chetner, M. B.
Amin, M. B.
Bruner, D. W.
Zietman, A. L.
Den, R. B.
Leibenhaut, M. H.
Longo, J. M.
Bahary, J. P.
Rosenthal, S. A.
Souhami, L.
Michalski, J. M.
Hartford, A. C.
Amin, P. P.
Roach III, M.
Yee, D.
Efstathiou, J. A.
Rodgers, J. P.
Feng, F. Y.
Shipley, W. U.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (01): : 265 - 265
[34] Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study
Hamilton, C. A.
Miller, A.
Casablanca, Y.
Horowitz, N. S.
Rungruang, B.
Krivak, T. C.
Richard, S. D.
Rodriguez, N.
Birrer, M. J.
Backes, F. J.
Geller, M. A.
Quinn, M.
Goodheart, M. J.
Mutch, D. G.
Kavanagh, J. J.
Maxwell, G. L.
Bookman, M. A.
GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 275 - 280
[35] Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Bradley, Jeffrey D.
Hu, Chen
Komaki, Ritsuko R.
Masters, Gregory A.
Blumenschein, George R.
Schild, Steven E.
Bogart, Jeffrey A.
Forster, Kenneth M.
Magliocco, Anthony M.
Kavadi, Vivek S.
Narayan, Samir
Iyengar, Puneeth
Robinson, Clifford G.
Wynn, Raymond B.
Koprowski, Christopher D.
Olson, Michael R.
Meng, Joanne
Paulus, Rebecca
Curran, Walter J., Jr.
Choy, Hak
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 706 - +
[36] Short-term Endocrine Therapy Prior to and during Radiation Therapy Improves Overall Survival in Patients with T1b-T2b Adenocarcinoma of the Prostate and PSA ≤ 20: Initial Results of RTOG 94-08
McGowan, D. G.
Hunt, D.
Jones, C. U.
Amin, M.
Leibenhaut, M. H.
Husian, S. M.
Rotman, M.
Souhami, L.
Sandler, H.
Shipley, W. U.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 1 - 1
[37] Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer (vol 116, pg 533, 2023)
Caudell, Jj
Torres-Saavedra, Pa
Rosenthal, Di
Axelrod, Rs
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (03): : 774 - 776
[38] AN UPDATE OF RTOG 94-08: A PHASE III TRIAL EVALUATING SHORT-TERM ANDROGEN DEPRIVATION PRIOR TO AND DURING CONVENTIONAL-DOSE RADIATION THERAPY IN PATIENTS WITH T1B T2B PROSTATE CANCER AND A PSA OF 20NG/ML
Shipley, W. U.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S37 - S37
[39] Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
Bernsen, Emma C.
Hagleitner, Melanie M.
Kouwenberg, Theodorus W.
Hanff, Lidwien M.
FRONTIERS IN PHARMACOLOGY, 2020, 11
[40] Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non -Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
Lee, W. R.
Dignam, J. J.
Amin, M.
Bruner, D. W.
Low, D.
Swanson, G. P.
Shah, A. B.
D'Souza, D. P.
Michalski, J. M.
Dayes, I.
Seaward, S. A.
Hall, W. A.
Nguyen, P. L.
Pisansky, T. M.
Faria, S. L.
Chen, Y.
Rodgers, J.
Sandler, H. M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S3 - S4

← 1 2 3 4 5 →